论文部分内容阅读
为评价BT减少气道平滑肌增生和通过血管扩张改善支气管功能的疗效,吸入高剂量皮质激素(ICS)-LABA和口服糖皮质激素(OCS),将仍有哮喘症状的患者随机分为对照或BT组。32例符合GINA标准的重症难治性哮喘患者入组,其中BT组15例,对照组17例。两组中各有约半数同时使用口服皮质激素和吸入ICS-LABA。研究
To evaluate the efficacy of BT in reducing airway smooth muscle proliferation and bronchial function via vasodilation, high dose corticosteroids (ICS) - LABA and oral glucocorticoid (OCS) were inhaled and patients with asthma symptoms were randomized to either control or BT group. Thirty-two patients with severe refractory asthma complying with GINA criteria were enrolled, of which 15 were in BT group and 17 in control group. About half of the two groups each use oral corticosteroids and inhaled ICS-LABA. the study